logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9428510 B1

PDFFull Text
Date of Patent:
Aug. 30, 2016

Filed:

Jul. 29, 2013

Derivatives of azaindazole or diazaindazole type for treating a cancer overexpressing trk

Applicant:

Pierre Fabre Medicament, Boulogne-Billancourt, FR;

Inventors:

Anna Kruczynski, Pompertuzat, FR;

Laurent Creancier, Portet sur Garonne, FR;

El Bachir Kaloun, Roquettes, FR;

Karim Bedjeguelal, Toulouse, FR;

Rémi Rabot, Toulouse, FR;

Assignee:

PIERRE FABRE MEDICAMENT, Boulogne-Billancourt, FR;

Attorney:

Birch, Stewart, Kolasch & Birch, LLP

Primary Examiner:

Taofiq A Solola

Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61K 31/437 (2006.01); A61K 31/496 (2006.01); A61K 31/4985 (2006.01); A61K 31/5025 (2006.01); A61K 31/519 (2006.01); C07D 471/04 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/437 (2013.01); A61K 31/496 (2013.01); A61K 31/4985 (2013.01); A61K 31/5025 (2013.01); A61K 31/519 (2013.01); A61K 45/06 (2013.01); C07D 471/04 (2013.01);
Abstract

The present invention relates to a compound of following formula (I) or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture, as well as pharmaceutical composition comprising such a compound, for use in the treatment of a cancer associated with the overexpression of at least one Trk protein.

Find Patent Forward Citations

Kruczynski, Anna. (2016). Derivatives of azaindazole or diazaindazole type for treating a cancer overexpressing trk (U.S. Patent No. 9428510). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9428510

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…